O. Odugbesan1, A. Addala2, K. Gandhi3, N. Rioles1, N. Hawa Yayah Jones4, R. Izquierdo5, K. Cossen6, J. Schmitt7, S. Agarwal8, G. Nelson9, S. Dei‐Tutu10, D. Maahs2O. Ebekozien1

Background and Aims: Inequities in the use of these diabetes devices persist with lower device use among Non‐Hispanic Black and Hispanic patients compared to Non‐Hispanic White patients. We examined the role of diabetes provider implicit bias mediated by patient’s race in recommending devices.

Methods: Providers across seven US endocrinology centers electronically completed a Diabetes‐Provider Implicit Bias (D‐PIB) tool. This assessment contained a clinical vignette and ranking exercise. Providers were randomized and assigned identical case vignettes with different patient names as proxies of racial identity. Implicit bias was defined as providers recommending more technology for patients with an English‐sounding name. Provider characteristics were analyzed using descriptive statistics and multivariate regression.

Full study abstract listed under number EP294 / #172 at this link